Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117294) titled 'Darvyadi churna with Triphaladi Granules verus Rohitakadi churna with Triphaladi Granules in Type 2 Diabetes Mellitus with Non Alcoholic fatty liver disease Prameha with Medoroga' on Sept. 9.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: All India Institute of Ayurveda New Delhi

Condition: Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Recruitm...